The oligonucleotides clinical trial analysis report delivers important insights into ongoing research on 600+ ...

We appreciate you taking the time out of your busy schedules to attend our Investors Meeting for FY 2025 financial results, management priorities and business strategies. Today's session will begin ...

Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raisedCambridge, UK, 14 ...

PLC ("4basebio" or the "Company") 4basebio Launches Enzymatic ssDNA Platform Overcomes critical manufacturing and performance bottlenecks associated with traditional chemical synthesis, providing ...

May 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded ...

Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidanceThree presentations at upcoming TIDES USA ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes ...

(NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis® Manufacturing Platform and provide an update on ...

Storing genetic material as DNA or RNA is all well and good for life on Earth, but it would be entirely pointless if we couldn't do anything with it. To use our genetic blueprints, all organisms need ...

Scientists at Stanford University have discovered that DRT3, a unique defense system found in bacteria, creates DNA to protect against viral infections. DRT3 is made up of two different enzymes called ...

Scientists have just discovered an entirely new way that DNA can be synthesized. The business of constructing DNA (deoxyribonucleic acid, to give it its full name) usually requires a template that ...

Contemporary biosecurity frameworks reflect lessons drawn from twentieth-century bioweapons programs, when states pursued large-scale efforts to weaponize a relatively limited set of high-consequence ...